Hemostats & Tissue Sealants Market by Product Type (Hemostats, Tissue sealants), Application (Burn & Trauma Cases, Cardiovascular, General Surgeries), End User - Global Forecast 2024-2030

Hemostats & Tissue Sealants Market by Product Type (Hemostats, Tissue sealants), Application (Burn & Trauma Cases, Cardiovascular, General Surgeries), End User - Global Forecast 2024-2030


The Hemostats & Tissue Sealants Market size was estimated at USD 10.50 billion in 2023 and expected to reach USD 11.78 billion in 2024, at a CAGR 12.33% to reach USD 23.72 billion by 2030.Hemostats & tissue sealants are used in several surgical disciplines to stop bleeding mechanically or by augmenting the coagulation cascade. Tissue sealants are products that bind to and close cuts in tissue. The increasing aging population, the rising prevalence of chronic conditions and diseases, and the need for timely surgeries are expected to drive the market's growth. Several government initiatives to focus on wound closure management and easy availability of hemostats & tissue sealants are the market growth factors. However, the higher cost of surgical procedures, the rising prices of surgical products and treatments, and strict regulations regarding the utilization of hemostats & tissue sealants hamper the market growth. Technological advancement in hemostats & tissue sealants products and increasing use of biopolymer-based hemostats are expected to create a significant market opportunity in the forecasted period.Regional InsightsThe Americas has a significant presence in the hemostats & tissue sealants market owing to the growing prevalence of cardiovascular diseases, diabetes, and cancer and increasing health expenditure within the region. According to the National Health Expenditure Accounts, U.S. healthcare spending increased by 2.7% in 2021, reaching USD 4.3 trillion or USD 12,914 per person to address rising healthcare issues. The launch of advanced and innovative products, the rising number of surgeries, and the increasing demand for more effective and quicker healing post-surgery are enhancing the demand for hemostats & tissue sealants in the European region. The proliferating approvals and clearance of hemostats & tissue sealants have expanded the availability of new products in Europe. The hemostats & tissue sealants market is growing in Asia-Pacific due to increased medical tourism and surgical procedures volume.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Hemostats & Tissue Sealants Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Hemostats & Tissue Sealants Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Hemostats & Tissue Sealants Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Medical Solutions Group PLC, Aegis Lifesciences Private Limited., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Inc., CooperSurgical, Inc., CryoLife, Inc., CSL Behring, CuraMedical B.V., Grifols, S.A., Hemostasis, LLC, Hologic, Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., KAKEN PHARMACEUTICAL CO., LTD., KATSAN Katgüt Sanayi ve Tic. A.Ş., Medline Industries, LP., Medtronic PLC, Olympus Corporation, Owens & Minor, Pfizer, Inc., Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Thermo Fisher Scientific Inc., Vivostat A/S, and Zimmer Biomet.

Market Segmentation & Coverage



This research report categorizes the Hemostats & Tissue Sealants Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type
Hemostats
Active Hemostats

Flowable Hemostats

Mechanical Hemostats
Tissue sealants
Fibrin Sealants

Synthetic Sealants
Application
Burn & Trauma Cases
Cardiovascular
General Surgeries
Neurological
Orthopedic
Reconstructive Surgeries
Urological
End User
Ambulatory Surgical Centers
Hospitals
Specialty Clinics
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Hemostats & Tissue Sealants Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Hemostats & Tissue Sealants Market?
3. What are the technology trends and regulatory frameworks in the Hemostats & Tissue Sealants Market?
4. What is the market share of the leading vendors in the Hemostats & Tissue Sealants Market?
5. Which modes and strategic moves are suitable for entering the Hemostats & Tissue Sealants Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Hemostats & Tissue Sealants Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of chronic disorders and need for timely surgeries
5.1.1.2. Rise of biopolymer-based disposable hemostats
5.1.1.3. Availability of hemostats through trusted online medical device channels
5.1.2. Restraints
5.1.2.1. Low outlining quality and high costs of surgical sealants
5.1.3. Opportunities
5.1.3.1. Introduction of new-generation tissue sealants and hemostatic agents
5.1.3.2. Initiatives focusing on wound healing and closure management
5.1.4. Challenges
5.1.4.1. Strict standards regarding the utilization of hemostats & tissue sealants
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Hemostats & Tissue Sealants Market, by Product Type
6.1. Introduction
6.2. Hemostats
6.3.1. Active Hemostats
6.3.2. Flowable Hemostats
6.3.3. Mechanical Hemostats
6.3. Tissue sealants
6.4.1. Fibrin Sealants
6.4.2. Synthetic Sealants
7. Hemostats & Tissue Sealants Market, by Application
7.1. Introduction
7.2. Burn & Trauma Cases
7.3. Cardiovascular
7.4. General Surgeries
7.5. Neurological
7.6. Orthopedic
7.7. Reconstructive Surgeries
7.8. Urological
8. Hemostats & Tissue Sealants Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals
8.4. Specialty Clinics
9. Americas Hemostats & Tissue Sealants Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Hemostats & Tissue Sealants Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Hemostats & Tissue Sealants Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. Corza Medical Signs Definitive Agreement to Acquire Takeda's TachoSil Manufacturing Operations
12.3.2. New Product Launch & Enhancement
12.3.2.1. Olympus Launches EndoClot Hemostatic Agents and Submucosal Injection Agent in European Markets
12.3.2.2. Team Develops Extracellular Matrix-Based Sticky Sealants For Corneal Tissue Reconstruction
12.3.3. Investment & Funding
12.3.3.1. Cresilon Closes $25 Million in Series A-4 Financing to Accelerate Global Expansion and Bring Revolutionary Hemostatic Gel to Human Health Market
12.3.4. Award, Recognition, & Expansion
12.3.4.1. Advamedica Inc Announces FDA Clearance for Ax-Surgi Surgical Hemostat
12.3.4.2. Medcura Receives Breakthrough Device Designation for its LifeGel™ Absorbable Surgical Hemostat
12.3.4.3. ZEISS Receives FDA Clearance for MTLawton – A New Generation of Bipolar Forceps for Electrosurgery
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. Advanced Medical Solutions Group PLC
13.1.3. Aegis Lifesciences Private Limited.
13.1.4. B. Braun SE
13.1.5. Baxter International Inc.
13.1.6. Becton, Dickinson and Company
13.1.7. Cardinal Health, Inc.
13.1.8. CooperSurgical, Inc.
13.1.9. CryoLife, Inc.
13.1.10. CSL Behring
13.1.11. CuraMedical B.V.
13.1.12. Grifols, S.A.
13.1.13. Hemostasis, LLC
13.1.14. Hologic, Inc.
13.1.15. Integra LifeSciences Corporation
13.1.16. Johnson & Johnson Services, Inc.
13.1.17. KAKEN PHARMACEUTICAL CO., LTD.
13.1.18. KATSAN Katgüt Sanayi ve Tic. A.Ş.
13.1.19. Medline Industries, LP.
13.1.20. Medtronic PLC
13.1.21. Olympus Corporation
13.1.22. Owens & Minor
13.1.23. Pfizer, Inc.
13.1.24. Smith & Nephew PLC
13.1.25. Stryker Corporation
13.1.26. Teleflex Incorporated
13.1.27. Terumo Corporation
13.1.28. Thermo Fisher Scientific Inc.
13.1.29. Vivostat A/S
13.1.30. Zimmer Biomet
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. HEMOSTATS & TISSUE SEALANTS MARKET RESEARCH PROCESS
FIGURE 2. HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2023 VS 2030
FIGURE 3. HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HEMOSTATS & TISSUE SEALANTS MARKET DYNAMICS
FIGURE 7. HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 8. HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. HEMOSTATS & TISSUE SEALANTS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. HEMOSTATS & TISSUE SEALANTS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings